title: Fabry disease: a new challenge in endocrinology and metabolism?
authors.affiliation: Department of Medical Endocrinology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. ufeldt@rh.dk
authors.forename: U
authors.initials: U
authors.lastname: Feldt-Rasmussen
authors.forename: A K
authors.initials: AK
authors.lastname: Rasmussen
authors.forename: H
authors.initials: H
authors.lastname: Mersebach
authors.forename: K M
authors.initials: KM
authors.lastname: Rosenberg
authors.forename: L
authors.initials: L
authors.lastname: Hasholt
authors.forename: S A
authors.initials: SA
authors.lastname: Sorensen
mesh_terms: D017668:Age of Onset; D003937:Diagnosis, Differential; D000795:Fabry Disease / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism; D005260:Female; D006028:Glycosphingolipids / Q000378:metabolism*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D008297:Male; D016032:Randomized Controlled Trials as Topic; D014281:Trihexosylceramides / Q000378:metabolism*
chemical_list: D006028:Glycosphingolipids; D014281:Trihexosylceramides; C018549:globotriaosylceramide